AerSale Corporation
NASDAQ:ASLEAirlines, Airports & Air Services
-$0.11 today
- Market cap
- $242.47M
- Beta
- 0.27
- P/E (TTM)
- 25.5
- EPS (TTM)
- $0.25
Volume 0.30M
Average 0.37M
ASLE Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
AerSale CorporationNASDAQ: ASLE
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables declines year over year
Q1 FY2026 accounts receivables of $3.86M (cash outflow) fell 29.3% year over year, ahead of the -42.1% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +96.0% a year.
Context
- Accounts receivables amounted to 2.3% of revenue in FY2025, up 1.2 pp from a year earlier.
- Accounts receivables grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -29.3% holds above the trailing-twelve-month pace of -42.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (7.74M) USD
- Year-over-year change
- -95.2%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (7.74M) | -95.2% |
| FY2024 | 2024-12-31 | (3.97M) | +13.6% |
| FY2023 | 2023-12-31 | (4.59M) | -346.5% |
| FY2022 | 2022-12-31 | (1.03M) | +69.2% |
| FY2021 | 2021-12-31 | (3.34M) | — |
Accounts Receivables vs competitors
How ASLE compares with its peers on the latest reported figures
- ASLE's LTM Mar 2026 accounts receivables of $6.14M is the 3rd largest of the 11 companies compared; the peer median is $217.66K.
- Its year-over-year change of -42.1% is the 5th highest of 11, against a peer median of -62.8%.
- Accounts receivables amounts to 1.8% of revenue for ASLE, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $10.3M | -53.8% | -37.0% | 0.5% | |
| LTM Apr 2026 | $6.34M | -168.3% | — | 1.5% | |
| LTM Mar 2026 | $6.14M | -42.1% | +96.0% | 1.8% | |
| LTM Mar 2026 | $3.93M | +74.2% | — | 6.2% | |
| LTM Mar 2026 | $3.61M | -71.8% | — | 0.6% | |
| LTM Mar 2026 | $2.87M | -35.1% | -33.1% | 0.7% | |
| LTM Mar 2026 | $1.93M | +151.2% | -9.4% | 0.4% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $727.39K | -230.0% | — | 0.4% |
| LTM Mar 2026 | $435.33K | -73.4% | — | — | |
| LTM Mar 2026 | $200K | -132.1% | — | 0.1% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding ASLE) | $217.66K | -62.8% | -33.1% | 0.5% | |
Competitors are the stored peer set for ASLE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 36.12M | 43.86M | (5.56M) | 5.85M | 8.58M |
| Depreciation & Amortization | 13M | 11.86M | 10.82M | 16.41M | 19.89M |
| Deferred Income Tax | (3.19M) | (2.39M) | (916K) | 2.03M | 1.39M |
| Stock-Based Compensation | 12.72M | 16.5M | 12.05M | 4.35M | 4.89M |
| Change in Working Capital | 12.51M | (72.07M) | (190.18M) | (19.39M) | (61.49M) |
| Accounts Receivables | (3.34M) | (1.03M) | (4.59M) | (3.97M) | (7.74M) |
| Inventory | (35.67M) | (37.64M) | (168.63M) | (78.03M) | (54.8M) |
| Accounts Payables | 3.6M | 1.16M | 8.77M | 4.29M | (4.54M) |
| Other Working Capital | 47.92M | (34.56M) | (25.72M) | 58.32M | 5.59M |
| Other Non-Cash Items | 7.92M | 2.12M | (363K) | 1.93M | 3.78M |
| Operating Cash Flow | 79.08M | (113K) | (174.15M) | 11.18M | (22.97M) |
| Capital Expenditures | (3.89M) | (15.6M) | (11.36M) | (29.03M) | (6.08M) |
| Acquisitions (Net) | 17.1M | 0 | 14.45M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 56.97M | 0 | 12.9M | 2.22M |
| Investing Cash Flow | 13.2M | 41.37M | 3.09M | (16.13M) | (3.86M) |
| Debt Repayment | 0 | 0 | 36.2M | 3.49M | 71.16M |
| Common Stock Issued | 9.28M | 0 | 566K | 531K | 386K |
| Common Stock Repurchased | 0 | (22.2M) | 0 | 0 | (45M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (694K) | (2.05M) | (7.02M) | (250K) | (37K) |
| Financing Cash Flow | 8.59M | (24.26M) | 29.74M | 3.77M | 26.51M |
| Effect of Forex Changes | (1) | 0 | 0 | 0 | 0 |
| Net Change in Cash | 100.87M | 17M | (141.32M) | (1.18M) | (319K) |
| Free Cash Flow | 75.19M | (15.71M) | (185.51M) | (17.85M) | (29.05M) |
AerSale Corporation
NASDAQ:ASLE
Intrinsic Alpha fair value
Locked
Current Price
$5.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.